Metraipolis › archive › dc_3c0b284ebaeb

Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data — Europe PMC PMID:36943829

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36943829
DOI
10.1371/journal.pone.0280584
License (as archived)
CC0-1.0
Archived
2026-10-07T14:07:25.920Z
SHA-256 of the archived text
b957d2404214d764e445fe640f4aa22cf01fb7e3b07bc68a0461edb43837d4e7
Stable URL of this page
https://metraipolis.com/documento/dc_3c0b284ebaeb

How to cite

Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data — Europe PMC PMID:36943829 — Europe PMC (en), https://europepmc.org/article/MED/36943829 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_3c0b284ebaeb (Metraipolis archive dc_3c0b284ebaeb, sha256 b957d2404214d764e445fe640f4aa22cf01fb7e3b07bc68a0461edb43837d4e7)
BibTeX
@misc{dc3c0b284ebaeb,
  title = {Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data — Europe PMC PMID:36943829},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36943829},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_3c0b284ebaeb; sha256 b957d2404214d764e445fe640f4aa22cf01fb7e3b07bc68a0461edb43837d4e7},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36943829. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

This retrospective observational study aimed to gain a better understanding of the protective duration of prior SARS-CoV-2 infection against reinfection. The objectives were two-fold: to assess the durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection, and to evaluate the crude SARS-CoV-2 reinfection rate and associated risk factors. During the pandemic era time period from February 29, 2020, through April 30, 2021, 144,678,382 individuals with SARS-CoV-2 molecular diagnostic or antibody test results were studied. Rates of reinfection among index-positive individuals were compared to rates of infection among index-negative individuals. Factors associated with reinfection were evaluated using multivariable logistic regression. For both objectives, the outcome was a subsequent positive molecular diagnostic test result. Consistent with prior findings, the risk of reinfection among index-positive individuals was 87% lower than the risk of infection among index-negative individuals. The duration of protection against reinfection was stable over the median 5 months and up to 1-year follow-up interval. Factors associated with an increased reinfection risk included older age, comorbid immunologic conditions, and living in congregate care settings; healthcare workers had a decreased reinfection risk. This large US population-based study suggests that infection induced immunity is durable for variants circulating pre-Delta predominance.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2023 (prima pubblicazione 2023-03-21).
Identificativi: PMID 36943829 · PMCID PMC10045607 · DOI 10.1371/journal.pone.0280584.
Descrittori MeSH principali: COVID-19; SARS-CoV-2.
Pagina: https://europepmc.org/article/MED/36943829 — https://doi.org/10.1371/journal.pone.0280584. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T14:02:28.630Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.